NCT04627402 (CONTE) is a NA clinical trial of Conbercept and TA in Diabetes Mellitus, Type 2, sponsored by Zhongshan Ophthalmic Center, Sun Yat-sen University.

Who is sponsoring NCT04627402?

NCT04627402 is sponsored by Zhongshan Ophthalmic Center, Sun Yat-sen University.

What drugs are being tested in NCT04627402?

Interventions in NCT04627402: Conbercept and TA, Conbercept.

What condition does NCT04627402 study?

NCT04627402 studies Diabetes Mellitus, Type 2, Macular Edema.

Is NCT04627402 still recruiting?

NCT04627402 is currently status unknown. Last updated 17 November 2020.

Last reviewed 2020-11-17 · How we verify

NCT04627402: CONTE

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Effects of Adding Triamcinolone Acetonide to Conbercept Treatment for Refractory Diabetic Macular Edema (CONTE)

Status unknown NA Last updated 17 November 2020

What this trial tests

NA trial testing Conbercept and TA in Diabetes Mellitus, Type 2 in 50 participants. Status unknown.

Timeline

12 November 2020

Primary endpoint
1 June 2021

31 December 2021

Quick facts

Lead sponsor	Zhongshan Ophthalmic Center, Sun Yat-sen University
Phase	NA
Status	Status unknown
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	single
Primary purpose	treatment
Enrollment	50
Start date	12 November 2020
Primary completion	1 June 2021
Estimated completion	31 December 2021
Sites	1 location across China

Drugs / interventions tested

Conbercept and TA — full drug profile →
Conbercept — full drug profile →

Conditions studied

Diabetes Mellitus, Type 2 — all drugs for Diabetes Mellitus, Type 2 →
Macular Edema — all drugs for Macular Edema →

Sponsor

Zhongshan Ophthalmic Center, Sun Yat-sen University

Who can join

18 and older, any sex, with Diabetes Mellitus, Type 2 or Macular Edema. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study aimed to compare intravitreous conbercept alone with conbercept plus intravitreous triamcinolone acetonide in DME eyes which showed limited response to anti-VEGF treatment after one injection.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Diabetes Mellitus, Type 2

Currently open trials in the same condition.

NCT07415954 — A Research Study Comparing How Well Different Doses of the Medicine NNC0662-0419 Lower Blood Sugar in People With Type 2 · Phase 2 · recruiting
NCT07532863 — A Real-world Study to Investigate Cardiovascular Risk Profile Among Newly Diagnosed Type 2 Diabetes Mellitus (T2DM) Part · recruiting
NCT07336329 — Continuous Glucose Monitoring in Non-Insulin Treated Type 2 Diabetes: Continuous vs. Periodic Use · NA · recruiting
NCT07242469 — A Clinical Trial of MK-1403 in Participants With Type 2 Diabetes Mellitus (MK-1403-006) · Phase 1 · recruiting
NCT07444203 — Transformative Research in Diabetic Nephropathy 2.0 · recruiting

Other Zhongshan Ophthalmic Center, Sun Yat-sen University trials

Trials by the same sponsor.

NCT07524725 — Effect of Behavioral Intervention (Baduanjin Alone or Laughter Exercise Plus Artificial Tears) Versus Artificial Tear on · NA · not yet recruiting
NCT07096622 — Efficacy of Visual and Perceptual Training on Visual Function for Operative Congenital Ectopia Lentis Children · NA · not yet recruiting
NCT06098677 — Effect of Carotenoids Supplementation on Visual Function in Chinese Subjects · NA · not yet recruiting
NCT07512115 — The Impact of 'A Miss Is as Good as a Mile': Is Compensation Necessary for Minimal Ocular Deviation in Myopic Laser Surg · NA · not yet recruiting
NCT07512089 — Comparison of PRESBYOND Laser Blended Vision and Conventional Monovision LASIK in Individuals With Presbyopia: A Randomi · NA · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04627402 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Zhongshan Ophthalmic Center, Sun Yat-sen University
Last refreshed: 17 November 2020

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04627402.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing